T1	Pharmacodynamic_phenotype	16 57	effect of combining aspirin and celecoxib
T2	Limited_variation	73 104	UGT1A6 T181A and R184S variants
T3	Disease	133 151	Adenoma Prevention
T4	Chemical	157 172	Celecoxib ( APC
T5	Chemical	234 255	aspirin after removal
T6	Disease	259 282	adenomas and randomized
T7	Chemical	286 302	placebo , 200-mg
T8	Chemical	346 360	ib for 3 years
R1	isAssociatedWith	Arg1:T1	Arg2:T2
R2	influences	Arg1:T1	Arg2:T4
R3	influences	Arg1:T1	Arg2:T5
R4	influences	Arg1:T1	Arg2:T6
R5	influences	Arg1:T1	Arg2:T7
R6	influences	Arg1:T1	Arg2:T8
R7	isAssociatedWith	Arg1:T2	Arg2:T1
R8	isAssociatedWith	Arg1:T2	Arg2:T3
R9	isAssociatedWith	Arg1:T2	Arg2:T4
R10	isAssociatedWith	Arg1:T2	Arg2:T5
R11	isAssociatedWith	Arg1:T2	Arg2:T6
R12	isAssociatedWith	Arg1:T2	Arg2:T7
R13	isAssociatedWith	Arg1:T2	Arg2:T8
R14	isAssociatedWith	Arg1:T3	Arg2:T1
R15	isAssociatedWith	Arg1:T3	Arg2:T2
R16	influences	Arg1:T3	Arg2:T4
R17	influences	Arg1:T3	Arg2:T5
R18	treats	Arg1:T3	Arg2:T6
R19	influences	Arg1:T3	Arg2:T7
R20	influences	Arg1:T3	Arg2:T8
R21	treats	Arg1:T4	Arg2:T3
R22	influences	Arg1:T4	Arg2:T5
R23	treats	Arg1:T4	Arg2:T6
R24	influences	Arg1:T4	Arg2:T7
R25	influences	Arg1:T4	Arg2:T8
R26	treats	Arg1:T5	Arg2:T3
R27	influences	Arg1:T5	Arg2:T4
R28	influences	Arg1:T5	Arg2:T6
R29	influences	Arg1:T5	Arg2:T7
R30	influences	Arg1:T5	Arg2:T8
R31	isAssociatedWith	Arg1:T6	Arg2:T1
R32	isAssociatedWith	Arg1:T6	Arg2:T2
R33	influences	Arg1:T6	Arg2:T3
R34	influences	Arg1:T6	Arg2:T4
R35	influences	Arg1:T6	Arg2:T5
R36	influences	Arg1:T6	Arg2:T7
R37	influences	Arg1:T6	Arg2:T8
R38	isAssociatedWith	Arg1:T7	Arg2:T1
R39	isAssociatedWith	Arg1:T7	Arg2:T2
R40	treats	Arg1:T7	Arg2:T3
R41	influences	Arg1:T7	Arg2:T4
R42	influences	Arg1:T7	Arg2:T5
R43	treats	Arg1:T7	Arg2:T6
R44	influences	Arg1:T7	Arg2:T8
R45	isAssociatedWith	Arg1:T8	Arg2:T1
R46	isAssociatedWith	Arg1:T8	Arg2:T2
R47	treats	Arg1:T8	Arg2:T3
R48	influences	Arg1:T8	Arg2:T4
R49	influences	Arg1:T8	Arg2:T5
R50	treats	Arg1:T8	Arg2:T6
R51	influences	Arg1:T8	Arg2:T7
